"10.1371_journal.pone.0100292","plos one","2014-06-16T00:00:00Z","Giorgio Tasca; Mauro Monforte; Elisabetta Iannaccone; Francesco Laschena; Pierfrancesco Ottaviani; Emanuele Leoncini; Stefania Boccia; Giuliana Galluzzi; Marco Pelliccioni; Marcella Masciullo; Roberto Frusciante; Eugenio Mercuri; Enzo Ricci","Don Carlo Gnocchi Onlus Foundation, Milan, Italy; Institute of Neurology, Catholic University School of Medicine, Rome, Italy; Department of Radiology, Istituto Dermopatico dellImmacolata, IRCCS, Rome, Italy; Institute of Hygiene-Department of Public Health, Catholic University School of Medicine, Rome, Italy; Cellular Biology and Neurobiology Institute, CNR, Rome, Italy; Unione Italiana Lotta Distrofia Muscolare (UILDM) Rome Section, Rome, Italy; IRCCS Santa Lucia Foundation, Rome, Italy; Neurophysiopathology Unit, Columbus Hospital, Catholic University School of Medicine, Rome, Italy; Pediatric Neurology Unit, Catholic University School of Medicine, Rome, Italy","Conceived and designed the experiments: GT ER. Performed the experiments: GT EI FL PO GG MP M. Masciullo RF ER. Analyzed the data: GT M. Monforte EL SB EM ER. Contributed reagents/materials/analysis tools: GT ER. Contributed to the writing of the manuscript: GT M. Monforte EM ER.","The authors of this manuscript have the following competing interests. EM has served on scientific advisory boards for Acceleron Pharma, Prosensa, and PTC Therapeutics; he receives research support from the European Union, Parent Project NL, SMA Europe, and Italian Telethon; he is receiving funding for trials from GlaxoSmithKline; and he has received funding for trials from Trophos and PTC Therapeutics. The other authors have declared that no competing interests exist. The authors also hereby confirm that what is disclosed in the competing interests section does not alter adherence to PLOS ONE policies on sharing data and materials.","2014","06","Giorgio Tasca","GT",13,FALSE,2,7,2,NA,TRUE,TRUE,TRUE,3,"6;7;11",TRUE
